Bluejay Diagnostics (BJDX) EPS (Diluted) (2021 - 2026)
Bluejay Diagnostics (BJDX) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.51 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.18 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | -2.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.05 |
| Dec 31, 2025 | -3.18 |
| Sep 30, 2025 | -4.06 |
| Jun 30, 2025 | -5.67 |
| Mar 31, 2025 | -13.79 |
| Dec 31, 2024 | -31.23 |
| Sep 30, 2024 | -307.77 |
| Jun 30, 2024 | -1,037.39 |
| Mar 31, 2024 | -1,655.75 |
| Dec 31, 2023 | -3,548.43 |
| Sep 30, 2023 | -3,405.48 |
| Jun 30, 2023 | -4,700.61 |
| Mar 31, 2023 | -4,274.94 |
| Dec 31, 2022 | -3,952.74 |
| Sep 30, 2022 | -4,619.33 |
| Jun 30, 2022 | -3,374.56 |
| Mar 31, 2022 | -3,334.67 |
| Dec 31, 2021 | -5,579.59 |
| Sep 30, 2021 | -5,145.18 |
| Jun 30, 2021 | -5,262.52 |